San Francisco's Public Health Director Dr. Grant Colfax is stepping down after spending nearly six years as the city's ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

January 16, 2025 -- Today, Public Health Director Dr. Grant Colfax announced his resignation from the San Francisco Department of Public Health (SFDPH) after nearly six years.

Six-month outcomes of children and adolescents diagnosed with multisystem inflammatory syndrome in children (MIS-C) after ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

The European Commission (EC) has granted marketing authorisation under exceptional circumstances for InflaRx’s Gohibic ...

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant ...

Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after ...